Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Debt Ratio (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Debt Ratio for 9 consecutive years, with 0.17 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 340.33% to 0.17 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17 through Dec 2025, up 340.33% year-over-year, with the annual reading at 0.17 for FY2025, 340.33% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.17 at Myriad Genetics, up from 0.16 in the prior quarter.
  • The five-year high for Debt Ratio was 0.17 in Q4 2025, with the low at 0.03 in Q2 2023.
  • Average Debt Ratio over 4 years is 0.07, with a median of 0.04 recorded in 2024.
  • The sharpest move saw Debt Ratio surged 3367.42% in 2021, then rose 7.65% in 2024.
  • Over 4 years, Debt Ratio stood at 0.08 in 2021, then tumbled by 56.12% to 0.03 in 2023, then rose by 14.76% to 0.04 in 2024, then soared by 340.33% to 0.17 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.17, 0.16, and 0.09 for Q4 2025, Q3 2025, and Q2 2025 respectively.